| Literature DB >> 34473953 |
Xin Luo1, Ouyang Chen2, Zilong Wang3, Sangsu Bang3, Jasmine Ji3, Sang Hoon Lee4, Yul Huh2, Kenta Furutani3, Qianru He3, Xueshu Tao3, Mei-Chuan Ko5, Andrey Bortsov3, Christopher R Donnelly3, Yong Chen6, Andrea Nackley7, Temugin Berta4, Ru-Rong Ji8.
Abstract
Although sex dimorphism is increasingly recognized as an important factor in pain, female-specific pain signaling is not well studied. Here we report that administration of IL-23 produces mechanical pain (mechanical allodynia) in female but not male mice, and chemotherapy-induced mechanical pain is selectively impaired in female mice lacking Il23 or Il23r. IL-23-induced pain is promoted by estrogen but suppressed by androgen, suggesting an involvement of sex hormones. IL-23 requires C-fiber nociceptors and TRPV1 to produce pain but does not directly activate nociceptor neurons. Notably, IL-23 requires IL-17A release from macrophages to evoke mechanical pain in females. Low-dose IL-17A directly activates nociceptors and induces mechanical pain only in females. Finally, deletion of estrogen receptor subunit α (ERα) in TRPV1+ nociceptors abolishes IL-23- and IL-17-induced pain in females. These findings demonstrate that the IL-23/IL-17A/TRPV1 axis regulates female-specific mechanical pain via neuro-immune interactions. Our study also reveals sex dimorphism at both immune and neuronal levels.Entities:
Keywords: IL-17; IL-23; dorsal root ganglion; estrogen receptor α; human; macrophage; mechanical allodynia; nociceptor; nonhuman primate; sex dimorphism
Mesh:
Substances:
Year: 2021 PMID: 34473953 PMCID: PMC8425601 DOI: 10.1016/j.neuron.2021.06.015
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 18.688